| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CNS Pharmaceuticals, Inc. | Director | Option to purchase common stock | 1,517 | 17 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CNSP | CNS Pharmaceuticals, Inc. | 17 Nov 2025 | 1 | $0 | 4 | Director | 19 Nov 2025, 17:00 |
| CNSP | CNS Pharmaceuticals, Inc. | 08 Apr 2024 | 2 | $0 | 4 | Director | 10 Apr 2024, 21:52 |
| CNSP | CNS Pharmaceuticals, Inc. | 01 Feb 2024 | 3 | +$10,000 | 4 | Director | 06 Feb 2024, 10:28 |
| CNSP | CNS Pharmaceuticals, Inc. | 21 Sep 2023 | 1 | $0 | 4/A | Director | 12 Oct 2023, 18:01 |
| CNSP | CNS Pharmaceuticals, Inc. | 19 Apr 2023 | 1 | +$4,250 | 4 | Director | 21 Apr 2023, 07:58 |
| CNSP | CNS Pharmaceuticals, Inc. | 10 Apr 2023 | 1 | +$5,308 | 4 | Director | 17 Apr 2023, 08:17 |
| CNSP | CNS Pharmaceuticals, Inc. | 15 Jul 2021 | 1 | $0 | 4 | Director | 16 Jul 2021, 17:00 |